25-50% Off

Texas InstrumentsTLV73312PDQNTLinear Regulators

LDO Regulator Pos 1.2V 0.3A 4-Pin X2SON EP T/R

Keep the energy stable for every system by using this LDO TLV73312PDQNT linear regulator by Texas Instruments. It has an overall accuracy of ±1 %. Its typical dropout voltage at current is 0.125@300mA V. This voltage regulation device's single output can produce a current up to 0.3 A. The best way to provide power to your application is by using this, which needs a voltage of at least 1.4 V and no higher than 5.5 V. With an adjustable output that has a voltage of 1 to 3.3 V, this is power management at its best. By operating at a load regulation of 16mV(Typ) and line regulation of 1mV/V(Typ) you can provide a constant voltage at your output. In order to ensure safe delivery and enable quick mounting of this component after delivery, it will be encased in tape and reel packaging during shipment. Its polarity is positive. This voltage regulation device has a minimum operating temperature of -40 °C and a maximum of 125 °C. The maximum dropout voltage is 0.42@300mA|0.37@300mA|0.27@300mA|0.26@300mA|0.45@300mA|0.4@300mA|0.3@300mA|0.29@300mA|0.27@300mA V.

Import TariffMay apply to this part

250 parts: Ships tomorrow

    Total$0.15Price for 1

    • Service Fee  $7.00

      Ships tomorrow

      Ships from:
      United States of America
      Date Code:
      2141+
      Manufacturer Lead Time:
      12 weeks
      Minimum Of :
      1
      Maximum Of:
      250
      Country Of origin:
      China
         
      • Price: $0.1539
      Spliced leader/trailer tape per EIA standards Leader tape:400mm=15.75'; Trail tape:160mm=6.3' more information
    • Ships tomorrow

      Ships from:
      United States of America
      Date Code:
      2141+
      Manufacturer Lead Time:
      12 weeks
      Country Of origin:
      China
      • In Stock: 250 parts
      • Price: $0.1539

    Design AI-powered medical devices

    Explore system design tips, part recs and AI insights to help you build faster, safer diagnostic and therapy solutions—all in Arrow’s latest white paper.